Abstract: Magnetic nanoparticles are renowned for their anticancer activity. Recent studies have elucidated that magnetic nanoparticles induce cytotoxicity by induction of apoptosis in cancer cells. The magnetic nanoparticles can also be biosynthesized, and this presents an added advantage along with the concept of limited toxicity to normal cells. This review focuses on the mechanistic studies performed on the anticancer activity of different types of magnetic nanoparticles. Apoptosis was shown to be the most plausible reason behind the cell death mediated by various types of magnetic nanoparticles.
Introduction
Cancer is the leading cause of death worldwide. In 2016, 1,685,210 new cancer cases and 595,690 cancer deaths are expected to occur in the United States alone [1] . More effective approaches to fight cancer have become the need of the hour. Nanotechnology is recently spotted as an immense field of interest funded by billions of dollars [2] . It has the potential to develop novel and highly effective therapeutic and diagnostic agents [3] . Nanomedicine has led to the increased exploitation of magnetic nanomaterials [4] . They were reported to possess potential applications in cancer therapy through different molecular mechanisms as well as direct cell killing mechanisms, such as magnetic hyperthermia and photothermal treatment [3, 5] . Magnetic nanoparticles can be classified into five different types: ferromagnetic, paramagnetic, diamagnetic, antiferromagnetic, and ferrimagnetic [6] . They have been mostly tested against breast, cervical, liver, and leukemia cancer cell lines. The most well-known mechanism by which anticancer therapeutic agents induce cell death is by the induction of apoptosis [7] . DNA fragmentation and caspase activation are the main hallmarks of apoptosis [8] . In addition to apoptosis, other mechanisms involved are autophagy and nanoparticle-mediated necrosis [9] . In the current report, the mechanism of action of different magnetic nanoparticles was reviewed and analyzed to investigate the most probable cause of cell death in cancer cells treated with these nanoparticles. This will differentiate the molecular mechanisms involved and will bring new insights enabling researchers to select the most appropriate nanoparticle formulation for targeting certain types of cancers.
2 Mechanistic studies on the anticancer activity of magnetic nanoparticles 2.1 Ferromagnetic nanoparticles
Iron oxide nanoparticles
Iron oxide (Fe 3 O 4 ) nanoparticles were efficient in anticancer activity against a breast cancer cell line (MCF-7). The authors revealed that the genotoxic effects and killing of breast cancer cells were possibly mediated by reactive oxygen species (ROS) and oxidative stress [10] . Iron oxide nanoparticles in combination with static magnetic field increased the apoptotic potential of doxorubicin by sensitizing MCF-7 cells [11] . Cinnamaldehyde-tagged Fe 3 O 4 nanoparticles capped with glycine and pluronic polymer induced cytotoxicity in both ER/PR-positive/Her2 negative (MCF7) and ER/PR-negative/Her2 negative (MDAMB231) breast cancer cells, and altered their migration by reduction in the expression of matrix metalloproteinase-2 (MMP-2). Loss of mitochondrial membrane potential and activation of caspase-3 resulted in apoptosis in both cell lines [12] . 10-Hydroxycamptothecin-loaded Fe 3 O 4 nanoparticles resulted in cell death of HCC827 (human non-small-cell lung cancer) cells, through the induction of apoptosis by the caspase-8 pathway [13] . α-d-Glucose was used to biosynthesize Fe 3 O 4 nanoparticles for testing against human hepatocellular carcinoma HepG2 and human lung adenocarcinoma (A549) cells. Quantitative PCR showed that the tumor suppressor gene p53 and apoptotic genes (caspase-3 and caspase-9) were upregulated. The nanoparticles were efficient in anticancer activity by induction of apoptosis in both cell lines [14] . NQO1 is an enzyme expressed on some types of cancer cells that activate the anticancer drug β-lapachone (β-lap). SPION (superparamagnetic iron oxide nanoparticles) micelles from rhodamine-conjugated PEG-b-PDPA copolymer when tested against A549 cells (NQO1-overexpressing) resulted in elevated levels of ROS generation, leading to catalase-sensitive, NQO1-specific β-lap drug cytotoxicity [15] . When conjugated with gambogic acid, Fe 3 O 4 nanoparticles upregulated the expression of Bax, caspase-9, and caspase-3, and downregulated the Bcl-2 gene resulting in induction of apoptosis, according to the authors in Capan-1 pancreatic cancer cells [16] . When HT29 human colon adenocarcinoma cell lines were treated with an iron oxide nanoparticles-doxorubicin conjugate, cell death through induction of late apoptosis was reported [17] . Carbon-encapsulated iron nanoparticles induced cell death by apoptosis in human (HTB-140) and mouse melanoma (B16-F10) cell lines [18] . Docetaxel-loaded superparamagnetic iron oxide nanoparticles induced apoptosis in C4-2 and PC-3 prostate cancer cells by the induction of apoptotic protein expression, downregulation of antiapoptotic proteins, and inhibition of chemoresistant proteins such as MDR1 [19] . Carbon-encapsulated iron nanoparticles induced mitochondrial and nucleus targeted cytotoxicities in a dose-and time-dependent manner in murine glioma cells (GL261). The synthesized nanoparticles decreased the mitochondrial membrane potential, an early indicator of apoptosis, and elevated pro-apoptotic signals. Cell cycle arrest occurred in the S and G2/M phases [20] .
Nickel zinc ferrite nanoparticles
When tested against human breast cancer (MCF7), colon (HT29), and liver (HepG2) cells, the nickel zinc ferrite nanoparticles resulted in the suppression of proliferation and induction of apoptosis through the activation of caspase-9 [21] . In another study, the same nanoparticles induced cytotoxicity through the induction of apoptosis by increasing the expression of pro-apoptotic genes (Bax, p53, and cytochrome c) and suppressing the expression of an antiapoptotic gene (Bcl-2) in a time-and dose-dependent manner against cancer cells of epithelial origin (MCF-7, HT29, and HepG2) [22] .
Magnesium ferrite nanoparticles
MgFe 2 O 4 nanoparticles induced apoptosis and necrosis in a dose-dependent manner against MCF-7 cells. The possible cytotoxic effect was correlated to free radical generation by iron through Fenton and/or Haber-Weiss reactions, as stated by the authors [23] .
Paramagnetic nanoparticles 2.2.1 Biosynthesized palladium nanoparticles
Against human ovarian cancer A2780 cells, palladium nanoparticles induced cell death by caspase-dependent apoptosis. Effects that have been observed were cell viability inhibition, elevated lactate dehydrogenase (LDH) leakage and ROS generation, induction of autophagy and consequent cell death, enhanced caspase-3 activity, and genotoxicity. According to the authors, ROS-mediated oxidative stress played a crucial role in the impairment of the mitochondrial membrane potential [24] . Palladium nanoparticles induced apoptotic cell death in HeLa cell lines by the activation of cytochrome c and caspase-3, and downregulation of Bcl-2 and Bcl-xL [25] . Against the same HeLa cell line, the palladium nanoparticles in combination with platinum (bimetallic) were efficient in inducing apoptosis [26] . It can be noted that palladium nanoparticles are efficient against cancers of ovarian origin, suggesting them to be a good candidate to treat such kind of cancers.
Cerium oxide nanoparticles
Among eight different cell lines tested with cerium oxide nanoparticles, IC 50 was only reached in two of them, namely melanoma (518A2) and colorectal adenocarcinoma (HT-29) cells. ROS-induced changes were the rationale behind the cell death induced by the nanoparticles [27] . Against the A549 cell line, cerium oxide nanoparticles reduced cell viability, induced oxidative stress thereby leading to elevated levels of malondialdehyde and LDH, directing to lipid peroxidation and membrane damage [28] . Concentration-dependent increase in Bax, cytochrome c, caspase-9, Apaf-1, and decrease in Bcl-2 protein expression were observed when cerium oxide nanoparticles were treated against A549 cells. Upregulated expression of caspase-3 and poly (ADP-ribose) polymerase illustrates that mitochondria-mediated apoptosis was the reason behind the cell death [29] . These findings may suggest the possibility of using cerium oxide nanoparticles specifically against adenocarcinoma.
Titanium dioxide nanoparticles
When tested against MCF-7 cells, titanium dioxide nanoparticles resulted in apoptotic cell death by upregulation of cytochrome c [30] . When co-administered with doxorubicin against the human SMMC-7721 hepatocarcinoma cells, titanium dioxide nanoparticles elevated the expression of pro-apoptotic proteins such as Bax and caspase-3, and downregulated the expression of antiapoptotic Bcl-2. An increase in the ratio of Bax/Bcl-2 expression led to apoptosis [31] .
Platinum nanoparticles
Tea polyphenol-fabricated platinum nanoparticles were tested against cervical cancer cells (SiHa). The nanoparticles induced cell cycle arrest in the G2/M phase and elevated the cell count in the sub-G 0 cell death phase. The authors suggested that apoptosis could be the rationale behind the cell death because the cells that emerge from G2 arrest will advance to apoptosis [32] . Bimetallic Au@ Pt nanostructures induced cell death in SiHa cells by cell shrinkage, intra-nucleosomal DNA fragmentation, and chromatin condensation. Apoptosis was induced through the G2/M phase check points [33] . When tested against human glioblastoma cells (U251), platinum nanoparticles induced cell death by apoptosis through p53 activation that was a result of genotoxicity [34] .
Neodymium oxide nanoparticles
Neodymium, a rare earth element, could be used in cancer treatment. Nano-sized neodymium oxide was reported to induce substantial vacuolization and cell death in nonsmall cell lung cancer NCI-H460 cells at the micromolar level. The induced cell death did not involve caspases and the apoptotic pathway. There were evidences of autophagy accomplices such as S-phase cell cycle arrest, mild disruption of mitochondrial membrane potential, and inhibition of proteasome activity. These results confirmed by electron microscopy and acridine orange staining revealed extensive autophagy in the cytoplasm of the cells treated by neodymium nanoparticles [35] .
Diamagnetic nanoparticles 2.3.1 Zinc oxide nanoparticles
Zinc oxide nanoparticles were tested against HepG2 cells at a concentration of 15 μg/ml for 24 h by Akhtar et al. Quantitative PCR and immunoblotting assays determined that the expression of proapoptotic (caspase-3 and Bax) and tumor suppressor (p53) genes were upregulated, whereas the antiapoptotic gene Bcl-2 was downregulated. DNA fragmentation was evident. Further, analysis of antioxidant enzymes and membrane lipid peroxidation showed that the mechanism of anticancer activity against HepG2 cells is by ROS generation and oxidative stress leading to an apoptotic trigger [36] . Similar results were observed in a similar study against HepG2 cells. Apoptosis and cytotoxicity were possibly correlated to ROS generation and oxidative stress [37] . In yet another study, mitochondrial dysfunction, inhibition of the PI3K/ Akt pathway, phosphorylation of ERK1/2, and enhancing the phosphorylation of JNK and P38 resulted in the induction of apoptosis in HepG2 cells treated with the combo of ZnO nanoparticles and isoorientin (a flavone of plant origin) [38] . In a similar study against HepG2 cells, the nanoparticles induced apoptotic cell death. Oxidative stress induced genotoxic effects. ROS generation resulted in decrease of mitochondrial membrane potential and an increase in the ratio of Bax/Bcl-2, indicative of the mitochondria-mediated pathway of apoptosis [39] . Against the human epithelial colorectal adenocarcinoma (Caco-2) cells, ZnO nanoparticles induced cytotoxicity by the release of ROS and consequent oxidative stress [40] . When treated against the glioblastoma cell line T98G, zinc oxide nanoparticles were genotoxic and efficient in induction of apoptosis [41] . Zinc oxide nanostructures induced cell death in human cerebral glioma tumor U87 and HeLa cell lines by cytogenetic damage and apoptosis [42] . Against the colon carcinoma cell (HT-29), ZnO nanoparticles loaded with doxorubicin induced cellular apoptosis by upregulation of Bax and downregulation of Bcl-2 [43] .
Biosynthesized silver nanoparticles (AgNPs)
AgNPs tested against the MCF-7 cell line showed that cell death occurred by apoptosis through the caspasedependent intracellular pathway. Antiapoptotic genes of the Bcl-2 family were downregulated, whereas the proapoptotic Bax was upregulated after treatment with the biosynthesized nanoparticles [44] . Cell death occurred in HepG2 cells by apoptosis induction through endocytosis when treated with AgNPs [45] . In yet another study, against HepG2 cells, AgNPs induced apoptosis by caspase-3 activation. DNA fragmentation stood supportive for this effect [46] . When tested against the Jurkat cell line (human lymphoma), at the IC 50 dose, the ROS levels elevated. There was a decrease in mitochondrial membrane potential, resulting in cell death via induction of apoptosis [47] . When treated against A549 cells, the nanoparticles induced cell death by the production of ROS and eventual apoptosis [48] . When treated against the colon cancer cell line HCT-116, the nanoparticles upregulated the expression of pro-apoptotic genes such as PUMA, caspase-3, caspase-8, and caspase-9, thereby leading to apoptotic cell death [49] . Silver nanoparticles biosynthesized using bacterial extract induced apoptosis in A549 cells by increased leakage of LDH, intracellular ROS generation, and decreased mitochondrial transmembrane potential [50] . Against COLO 205 (colon carcinoma) cells, AgNPs induced cell death through apoptosis by triggering the intracellular ROS generation and MMP loss, which resulted in DNA fragmentation and cell cycle arrest [51] .
Gold nanoparticles
In the human cervical cell line HeLa, biosynthesized gold nanoparticles were able to induce apoptosis by activation of caspases [52] . Gold nanoparticles were able to induce cell death in MCF-7 cells by apoptosis. The levels of p53, Bax, caspase-3, and caspase-9 were upregulated, and antiapoptotic Bcl-2 expression was downregulated in this study [53] . siRNA gold glyconanoparticles were used against the luciferase-CMT/167 adenocarcinoma cancer cell line. The results indicate that the nanoparticles induced the expression of proapoptotic proteins Fas/ CD95 and caspase-3 and caspase-9. Cell death occurred by an apoptotic trigger through the induction of caspases [54] . Methotrexate-loaded bovine serum albumin-capped gold nanoparticles tested against MCF-7 cells induced G 1 -S phase arrest and DNA fragmentation, eventually leading to apoptosis [55] . Modified gold nanoparticles having functional quinoline molecules induced cytotoxicity by apoptosis in MCF-7 cells [56] . Biosynthesized gold nanoparticles were cytotoxic toward human promyelocytic leukemia cells (HL-60). The authors did not perform a full mechanistic study for the noticed cytotoxicity [57] .
Copper nanoparticles
Copper nanoparticles induced apoptosis in U937 (human lymphoma) and HeLa cell lines, and were genotoxic toward the DNA [58] . Biosynthesized copper oxide nanoparticles when tested against HeLa cells were efficient in inducting apoptosis by ROS production and initiation of lipid peroxidation [59] . Ficus religiosa-derived copper oxide nanoparticles generated ROS and disrupted the mitochondrial membrane potential, leading to apoptosis in A549 cells [60] . In another study, a group of nanoparticles (copper oxide, silica, titanium dioxide, and ferric oxide) were evaluated against A549, human non-small cell lung cancer (H1650), and human nasopharyngeal carcinoma (CNE-2Z) cells. Copper oxide nanoparticles alone were found to be effective against the tested cell lines, and the mode of action in A549 cells was likely to be through autophagy [61] .
Selenium nanoparticles
Selenium nanoparticles prevented the aggressive nature and migration of HepG2 cells, arrested cell cycle at the G 0 /G 1 phase, and induced apoptotic cell death through activation of the caspase cascade [62] . Biosynthesized nanoparticles of selenium were cytotoxic toward MCF-7 cells by induction of apoptosis [63] . Anisomycin-loaded functionalized selenium nanoparticles induced cytotoxicity by entering the HepG2 cells via endocytosis. The nanoparticles arrested the cell cycle at the G 0 /G 1 phase through the activation of the cyclin-dependent kinase inhibitors with inhibition of CDK-2 and ICBP90. The expression of cleaved caspase-3, caspase-8, and caspase-9 was elevated, eventually leading to apoptosis [64] .
Antiferromagnetic

Cobalt oxide nanoparticles
Chitosan-modified cobalt oxide nanoparticles were effective in causing cell death in Jurkat cells. Apoptosis was the rationale behind, caused by the production of ROS and tumor necrosis factor (TNF)-α [65] . As TNF-α as an apoptotic stimulus characterizes the contribution of caspases, the role of caspases seems evident in that report. In a similar study, cobalt oxide nanoparticles induced cell death via apoptosis by downregulation of antiapoptotic proteins such as Bcl-2 and Bcl-xL in human colorectal cancer cell lines HT29 and SW620 [66] . The increase in pro-apoptotic markers and induction of ROS resulting in TNF-α expression that leads to cell death by activation of p38 MAPK, caspase-8, and caspase-3 were observed in human leukemic cell lines such as Jurkat, K562, and KG-1A when treated with cobalt oxide nanoparticles [67] .
Inconclusive mechanisms
A group of magnetic nanoparticles has been functionalized with different agents, and their cytotoxicity to cancer cells was evaluated. However, the anticancer effect observed might be partly due to the type of the assigned material as well. Accordingly, the observed effects may vary for same type of magnetic nanoparticle functionalized with different agents against the same cell line. In such kind of studies, there is a lack of information about the role of magnetic nanoparticles in the observed anticancer effects. The noted effect might be due to the assigned material or the magnetic nanoparticle or their synergism. Further studies are warranted for such kind of research to elucidate the exact mechanism involved [13, 16, 19, 31, 38, 43, 55, 56, 64] .
Discrepant effects of magnetic nanoparticles
Despite the prospective biomedical applications of AgNPs, their toxicity studies revealed that they are relatively toxic. The nanoparticle size, dose, and route of administration are the major factors behind the toxic effects [2] . A gold nanoparticle cytotoxicity study indicated that they were less toxic against peripheral blood mononuclear cells [57] . Iron oxide nanoparticles showed no toxicity to normal rat hepatocytes and human fetal lung cells (IMR-90) [14] . However, some studies suggested the cytotoxicity of iron oxide magnetic nanoparticles to be influenced by several factors, such as time and dose of the exposure [4] . Compared to the cytotoxicity against cancer cell lines, zinc oxide nanostructures were reported to be relatively less toxic to the normal human embryonic kidney cell lines [41, 42] , while they posed no toxicity on primary rat astrocytes and hepatocytes [36] . Although some reports indicated that magnetic nanoparticles were non-toxic to normal mammalian cells, others showed that they were relatively toxic and their toxicity may vary depending on other factors like time and dose of exposure, and the nanoparticle properties. For instance, the toxicity of titanium dioxide nanoparticles was significant and dose dependent in mouse fibroblast cells (L929) [68] . Due to the lack of complete toxicity studies for certain magnetic nanoparticles against all types of normal mammalian cells, it is still too early to resolve their safety. Prior to clinical trials for magnetic nanoparticles, it is strongly suggested to perform comprehensive cytotoxicity studies.
Conclusion
Most of the anticancer drugs trigger apoptosis, which is a vital mechanism in the anticancer effect, mediated by ROS and oxidative stress [7, 14] . Following a similar trend, in the current report, we may conclude that magnetic nanoparticles induced cell death through caspase-dependent apoptosis mediated by ROS and consequent oxidative stress against a variety of cell lines. Most of these nanoparticles were genotoxic toward cancer cells. Decrease in mitochondrial membrane potential, upregulation of pro-apoptotic proteins, and downregulation of antiapoptotic proteins were observed predominantly in all cancer cells treated with magnetic nanoparticles. Hence, the role of apoptosis is the most significant with respect to the anticancer effect of magnetic nanoparticles. In this review, we referred to some reports of synergism of magnetic nanoparticles with other cytotoxic agents. While the authors demonstrated the most likely mechanisms of action of these formulations, in which apoptosis was the most significant one as well, we believe further studies are necessary to elucidate the exact role of magnetic nanoparticles in the proposed mechanisms for such formulation. As these mechanisms are well portrayed for anticancer therapy, along with the consideration of safety, we suggest that magnetic nanoparticles could be a valuable candidate for future anticancer medications.
